Ignite Creation Date:
2025-12-24 @ 4:13 PM
Ignite Modification Date:
2025-12-25 @ 2:12 PM
Study NCT ID:
NCT03188666
Status:
COMPLETED
Last Update Posted:
2022-12-02
First Post:
2017-06-13
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Study to Examine the Safety, Tolerability and Effects on Abnormal Bone Formation of REGN2477 in Patients With Fibrodysplasia Ossificans Progressiva
Sponsor:
Regeneron Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-02-26
Start Date Type:
ACTUAL
Primary Completion Date:
2019-09-16
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-09-16
Completion Date Type:
ACTUAL
First Submit Date:
2017-06-13
First Submit QC Date:
None
Study First Post Date:
2017-06-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2022-09-15
Results First Submit QC Date:
None
Results First Post Date:
2022-12-02
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2022-12-02
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2022-11-04
Last Update Post Date:
2022-12-02
Last Update Post Date Type:
ACTUAL